Page last updated: 2024-12-06
quinotolast
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
quinotolast: an anti-allergy agent; FR 71021 is the monosodium salt [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 65871 |
CHEMBL ID | 2104625 |
SCHEMBL ID | 1814890 |
MeSH ID | M0201523 |
Synonyms (16)
Synonym |
---|
quinotolast |
4-oxo-1-phenoxy-n-(2h-tetrazol-5-yl)quinolizine-3-carboxamide |
suc3551a8u , |
4h-quinolizine-3-carboxamide, 4-oxo-1-phenoxy-n-1h-tetrazol-5-yl |
quinotolastum |
quinotolast [inn] |
unii-suc3551a8u |
4-oxo-1-phenoxy-n-1h-tetrazol-5-yl-4h-quinolizine-3-carboxamide |
quinotolastum [inn-latin] |
101193-40-2 |
CHEMBL2104625 |
SCHEMBL1814890 |
4-oxo-1-(phenoxy)-n-(2h-tetrazol-5-yl)quinolizine-3-carboxamide |
DTXSID40143768 |
Q27289403 |
EX-A5883 |
Research Excerpts
Pharmacokinetics
Excerpt | Reference | Relevance |
---|---|---|
" CL(int,in vivo) was calculated from in vivo pharmacokinetic data using two frequently used mathematical models (the well stirred and dispersion models)." | ( Utility of hepatocytes in predicting drug metabolism: comparison of hepatic intrinsic clearance in rats and humans in vivo and in vitro. Kagayama, A; Naritomi, Y; Sugiyama, Y; Terashita, S, 2003) | 0.32 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (6)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 5 (83.33) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.24
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.24) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 6 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |